Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1932 1
1937 1
1944 1
1950 1
1955 1
1958 2
1962 1
1963 3
1964 1
1967 2
1968 1
1970 1
1971 1
1973 3
1975 3
1976 1
1977 2
1978 9
1979 3
1980 3
1981 9
1982 7
1983 3
1984 9
1985 6
1986 13
1987 16
1988 17
1989 11
1990 14
1991 18
1992 17
1993 13
1994 14
1995 14
1996 12
1997 16
1998 15
1999 15
2000 11
2001 13
2002 14
2003 17
2004 22
2005 26
2006 28
2007 30
2008 21
2009 26
2010 43
2011 46
2012 45
2013 45
2014 46
2015 49
2016 72
2017 79
2018 90
2019 73
2020 66
2021 71
2022 80
2023 79
2024 70

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,296 results

Results by year

Filters applied: . Clear all
Page 1
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Gazeau N, Liang EC, Wu QV, Voutsinas JM, Barba P, Iacoboni G, Kwon M, Ortega JLR, López-Corral L, Hernani R, Ortiz-Maldonado V, Martínez-Cibrian N, Martinez AP, Maziarz RT, Williamson S, Nemecek ER, Shadman M, Cowan AJ, Green DJ, Kimble E, Hirayama AV, Maloney DG, Turtle CJ, Gauthier J. Gazeau N, et al. Among authors: williamson s. Transplant Cell Ther. 2023 Jul;29(7):430-437. doi: 10.1016/j.jtct.2023.04.001. Epub 2023 Apr 7. Transplant Cell Ther. 2023. PMID: 37031746 Free PMC article.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Lawson M, Cureton N, Ros S, Cheraghchi-Bashi A, Urosevic J, D'Arcy S, Delpuech O, DuPont M, Fisher DI, Gangl ET, Lewis H, Trueman D, Wali N, Williamson SC, Moss J, Montaudon E, Derrien H, Marangoni E, Miragaia RJ, Gagrica S, Morentin-Gutierrez P, Moss TA, Maglennon G, Sutton D, Polanski R, Rosen A, Cairns J, Zhang P, Sánchez-Guixé M, Serra V, Critchlow SE, Scott JS, Lindemann JPO, Barry ST, Klinowska T, Morrow CJ, Carnevalli LS. Lawson M, et al. Among authors: williamson sc. Cancer Res. 2023 Dec 1;83(23):3989-4004. doi: 10.1158/0008-5472.CAN-23-0694. Cancer Res. 2023. PMID: 37725704 Free PMC article.
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.
Pearsall SM, Williamson SC, Humphrey S, Hughes E, Morgan D, García Marqués FJ, Awanis G, Carroll R, Burks L, Shue YT, Bermudez A, Frese KK, Galvin M, Carter M, Priest L, Kerr A, Zhou C, Oliver TG, Humphries JD, Humphries MJ, Blackhall F, Cannell IG, Pitteri SJ, Hannon GJ, Sage J, Dive C, Simpson KL. Pearsall SM, et al. Among authors: williamson sc. J Thorac Oncol. 2023 Oct;18(10):1362-1385. doi: 10.1016/j.jtho.2023.07.012. Epub 2023 Jul 16. J Thorac Oncol. 2023. PMID: 37455012 Free PMC article.
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
Ghilardi G, Chong EA, Svoboda J, Wohlfarth P, Nasta SD, Williamson S, Landsburg JD, Gerson JN, Barta SK, Pajarillo R, Myers J, Chen AI, Schachter L, Yelton R, Ballard HJ, Hodges Dwinal A, Gier S, Victoriano D, Weber E, Napier E, Garfall A, Porter DL, Jäger U, Maziarz RT, Ruella M, Schuster SJ. Ghilardi G, et al. Among authors: williamson s. Ann Oncol. 2022 Sep;33(9):916-928. doi: 10.1016/j.annonc.2022.05.521. Epub 2022 Jun 9. Ann Oncol. 2022. PMID: 35690221 Free PMC article.
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Hopcroft L, Wigmore EM, Williamson SC, Ros S, Eberlein C, Moss JI, Urosevic J, Carnevalli LS, Talbot S, Bradshaw L, Blaker C, Gunda S, Owenson V, Hoffmann S, Sutton D, Jones S, Goodwin RJA, Willis BS, Rooney C, de Bruin EC, Barry ST. Hopcroft L, et al. Among authors: williamson sc. NPJ Breast Cancer. 2023 Aug 5;9(1):64. doi: 10.1038/s41523-023-00571-w. NPJ Breast Cancer. 2023. PMID: 37543694 Free PMC article.
Psychedelic-like Activity of Norpsilocin Analogues.
Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC. Sherwood AM, et al. Among authors: williamson se. ACS Chem Neurosci. 2024 Jan 17;15(2):315-327. doi: 10.1021/acschemneuro.3c00610. Epub 2024 Jan 8. ACS Chem Neurosci. 2024. PMID: 38189238 Free PMC article.
Advances in mass spectrometry-based glycomics.
Dong X, Huang Y, Cho BG, Zhong J, Gautam S, Peng W, Williamson SD, Banazadeh A, Torres-Ulloa KY, Mechref Y. Dong X, et al. Among authors: williamson sd. Electrophoresis. 2018 Dec;39(24):3063-3081. doi: 10.1002/elps.201800273. Epub 2018 Oct 9. Electrophoresis. 2018. PMID: 30199110 Review.
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.
Saeed A, Park R, Pathak H, Al-Bzour AN, Dai J, Phadnis M, Al-Rajabi R, Kasi A, Baranda J, Sun W, Williamson S, Chiu YC, Osmanbeyoglu HU, Madan R, Abushukair H, Mulvaney K, Godwin AK, Saeed A. Saeed A, et al. Among authors: williamson s. Nat Commun. 2024 Feb 20;15(1):1533. doi: 10.1038/s41467-024-45960-2. Nat Commun. 2024. PMID: 38378868 Free PMC article. Clinical Trial.
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022).
Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, Hora M, Kojima F, Kristiansen G, Kuroda N, López JI, Maclean F, Magi-Galluzzi C, Martignoni G, McKenney JK, Michalová K, Michal M, Mohanty SK, Netto GJ, Ohashi R, Ondič O, Osunkoya AO, Gomez MDPM, Petersson F, Picken MM, Pivovarcikova K, Rogala J, Shah RB, Siadat F, Skenderi F, Sperga M, Suster SM, Svajdler M, Tretiakova M, Trpkov K, Ulamec M, Williamson SR, Yang XJ, Zhou M, Vranic S, Vujanic G, Michal M. Alaghehbandan R, et al. Among authors: williamson sr. Mod Pathol. 2022 Dec;35(12):2023-2024. doi: 10.1038/s41379-022-01159-8. Mod Pathol. 2022. PMID: 36333474 Free article. No abstract available.
Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.
Mannan R, Wang X, Bawa PS, Chugh S, Chinnaiyan AK, Rangaswamy R, Zhang Y, Cao X, Smith SC, Trpkov K, Williamson SR, Sangoi AR, Mohanty S, McKenney JK, Gupta S, Magi-Galluzzi C, Argani P, Osunkoya AO, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Mannan R, et al. Among authors: williamson sr. Hum Pathol. 2023 Apr;134:102-113. doi: 10.1016/j.humpath.2022.12.013. Epub 2022 Dec 26. Hum Pathol. 2023. PMID: 36581128
1,296 results